Pharmafile - Research and Development News
Researchers at University College London have found that a commonly prescribed antidepressant, sertraline, works in unexpected ways, first relieving...
Novo Nordisk has unveiled new data for Tresiba, demonstrating that the drug lowered the overall risk of hypoglycaemia com with insulin glargine U300...
Biogen is planning a new trial of $1.7billion-a-year Spinraza to investigate much higher doses in spinal muscular atrophy (SMA) and thwart off...
New research on clinical trials between 2014 and 2016 raise “serious concerns about low standards” as over the three year period trials showed high...
Sanofi took the opportunity at the 55th annual European Association for the Study of Diabetes to present new data from the first randomised control...
Swiss drugmaker Novartis have stated that a British baby’s death this year after getting Novartis’ gene therapy Zolgensma, was not caused by a toxic...
UK drug watchdog NICE has announced its final draft guidance recommending Takeda’s subcutaneous injection Takhzyro for use on the NHS in England...
The FDA has acted under a new initiative in collaboration with the Australian Therapeutic Goods Administration (TGA) and Health Canada, conducting...
AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals in China for Linzess (linaclotide), a first-in-class new treatment...
A new method from Swiss Biotech Versantis promises to give far better immediate care and offer a treatment for a couple of rare forms of liver...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
